Immunis Partners with Japanese Drug Company Toray to Reverse Sarcopenia [Yahoo! Finance]
TORAY INDUS INC UNSP/ADR (TRYIY)
NASDAQ:AMEX Investor Relations:
toray.com/ir/index.html
Company Research
Source: Yahoo! Finance
disease and immune dysfunction, obtained a significant strategic milestone in partnering with Toray , a Japanese drug company part of the Toray Group . Founded in 1926, Toray has grown into a highly successful conglomerate known for its commitment to solving pressing global health and environmental challenges. With its production of various advanced material sciences, Toray has diversified expertise in industries including pharmaceuticals, electronics, textiles, and aerospace. Immunis licensed development and commercial rights to the Japan-commercially-approved drug called TRK-820, an opioid receptor agonist developed initially for the treatment of pruritus or sever itching. Immunis' formulation of TRK-820 shows pre-clinical benefits for sarcopenia, and may serve as a promising pharmaceutical complement to IMMUNA, Immunis' human-derived regenerative biologic published to reverse age-related muscle loss, promote muscle growth and function, and enhance metabolism. Immunis is current
Show less
Read more
Impact Snapshot
Event Time:
TRYIY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TRYIY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TRYIY alerts
High impacting TORAY INDUS INC UNSP/ADR news events
Weekly update
A roundup of the hottest topics
TRYIY
News
- Global $26 Billion Thermoplastic Composites Market Outlook, 2030: Asia-Pacific Presents the Most Lucrative Opportunities [Yahoo! Finance]Yahoo! Finance
- Recycled Carbon Fiber Market Report and Competitive Analysis 2024-2030, Featuring Procotex, Gen 2 Carbon, SGL Carbon, CFK Valley Recycling, Carbon Conversion, Vartega, Toray and Karborek [Yahoo! Finance]Yahoo! Finance
- Milled (Chopped) Carbon Fiber Market Share Estimated to be Worth USD 507.1 Million by 2034, at 11% CAGR: Prophecy Market Insights [Yahoo! Finance]Yahoo! Finance
- ALCANTARA FEATURED AT AIRCRAFT INTERIORS EXPO 2024 IN GERMANY [Yahoo! Finance]Yahoo! Finance
- Milled Carbon Fiber Market worth $302 million by 2029 - Exclusive Report by MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance